|
CDK19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.441800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.253200E-01 |
| Normal-vs-Stage2 |
5.315600E-01 |
| Normal-vs-Stage3 |
4.380400E-01 |
| Normal-vs-Stage4 |
4.137200E-01 |
| Stage1-vs-Stage2 |
9.256600E-01 |
| Stage1-vs-Stage3 |
2.790600E-01 |
| Stage1-vs-Stage4 |
2.531200E-01 |
| Stage2-vs-Stage3 |
2.820400E-01 |
| Stage2-vs-Stage4 |
3.112600E-01 |
| Stage3-vs-Stage4 |
6.857000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.591600E-01 |
| Normal-vs-AfricanAmerican |
7.171200E-01 |
| Normal-vs-Asian |
1.298430E-01 |
| Caucasian-vs-AfricanAmerican |
6.348000E-01 |
| Caucasian-vs-Asian |
4.122600E-01 |
| AfricanAmerican-vs-Asian |
4.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.455800E-01 |
| Normal-vs-Female |
1.313960E-01 |
| Male-vs-Female |
3.571900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.899800E-01 |
| Normal-vs-Extreme_Weight |
2.820200E-02 |
| Normal-vs-Obese |
2.323200E-01 |
| Normal-vs-Extreme_Obese |
1.569750E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.446160E-01 |
| Normal_Weight-vs-Obese |
7.618600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.981700E-02 |
| Extreme_Weight-vs-Obese |
2.599300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.976400E-01 |
| Obese-vs-Extreme_Obese |
4.984500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.609800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.122200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.639600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.204590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.490400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.288990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.598400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.499900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.647600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.602000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.364200E-01 |
| Normal-VS-Type2 PRCC |
3.312100E-02 |
| Normal-VS-KIRP CIMP |
9.964000E-03 |
| Normal-VS-Unclassified PRCC |
7.563400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.669790E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.616600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.892000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.4683999999926E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.257400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.158000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.051640E-02 |
| Normal-vs-N1 |
2.495900E-02 |
| Normal-vs-N2 |
2.309200E-01 |
| N0-vs-N1 |
1.723150E-03 |
| N0-vs-N2 |
9.067600E-01 |
| N1-vs-N2 |
4.419700E-03 |
|
|
